These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 538579)
1. Sequential analysis of urinary antigen(s) in patients with sarcoma. Huth JF; Gupta RK; Morton DL Surg Forum; 1979; 30():150-2. PubMed ID: 538579 [No Abstract] [Full Text] [Related]
2. Assessment of in vivo effectiveness of tumoricidal chemotherapy and radiation therapy by serial analysis of tumor-associated urinary antigen titers in patients with sarcoma. Huth JF; Gupta RK; Morton DL Cancer Treat Rep; 1981; 65(11-12):1037-42. PubMed ID: 7296549 [TBL] [Abstract][Full Text] [Related]
3. Presence of human tumor-associated antigen(s) in urine of patients with cancer. Gupta RK; Morton DL Surg Forum; 1975; 26():158-60. PubMed ID: 1216096 [No Abstract] [Full Text] [Related]
4. Purification of antigens from urine of a sarcoma patient by affinity chromatography. Huth JF; Gupta RK; Morton DL J Surg Oncol; 1981; 18(3):237-47. PubMed ID: 7311552 [No Abstract] [Full Text] [Related]
5. Detection of cancer-associated antigen(s) in urine of sarcoma patients. Gupta RK; Morton DL J Surg Oncol; 1979; 11(1):65-74. PubMed ID: 285312 [TBL] [Abstract][Full Text] [Related]
6. A prospective postoperative evaluation of urinary tumor-associated antigens in sarcoma patients. Correlation with disease recurrence. Huth JF; Gupta RK; Eilber FR; Morton DL Cancer; 1984 Mar; 53(6):1306-10. PubMed ID: 6692320 [TBL] [Abstract][Full Text] [Related]
7. [Adjuvant chemotherapy in soft tissue sarcomas]. Tièche M; Goldhirsch A; Brunner KW Schweiz Med Wochenschr; 1980 Mar; 110(10):374-9. PubMed ID: 7394467 [TBL] [Abstract][Full Text] [Related]
8. Development of an enzyme immunoassay to detect and quantitate tumor-associated antigens in the urine of sarcoma patients. Huth JF; Gupta RK; Morton DL Cancer; 1981 Jun; 47(12):2856-61. PubMed ID: 7020919 [TBL] [Abstract][Full Text] [Related]
9. Immunomic analysis of human sarcoma. Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin and dactinomycin therapy for advanced sarcomas. Brenner DE; Chang P; Wiernik PH Cancer Treat Rep; 1981; 65(3-4):231-6. PubMed ID: 6165466 [TBL] [Abstract][Full Text] [Related]
11. Sarcoma-specific antigens: detection by complement fixation with serum from sarcoma patients. Eilber FR; Morton DL J Natl Cancer Inst; 1970 Mar; 44(3):651-6. PubMed ID: 11515434 [No Abstract] [Full Text] [Related]
13. Advances in chemotherapy for patients with extremity soft tissue sarcoma. Eilber FC; Tap WD; Nelson SD; Eckardt JJ; Eilber FR Orthop Clin North Am; 2006 Jan; 37(1):15-22. PubMed ID: 16311108 [TBL] [Abstract][Full Text] [Related]
14. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line. Drewinko B; Montgomery CT; Trujillo JM Cancer Res; 1973 Mar; 33(3):601-5. PubMed ID: 4347719 [No Abstract] [Full Text] [Related]
15. Comparison of doxorubicin with cycloleucine in the treatment of sarcomas. Savlov ED; MacIntyre JM; Knight E; Wolter J Cancer Treat Rep; 1981; 65(1-2):21-7. PubMed ID: 7013976 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas. Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704 [TBL] [Abstract][Full Text] [Related]